Story Poster
Photo by John Jones/Icon Sportswire
Basketball Recruiting

Top-10 sophomore Ian Jackson talks recruitment and his game

May 26, 2022

Cardinal Hayes’ Ian Jackson is a prospect I’ve gotten to see plenty, of due to the fact I’m a New York City native, and one thing I’ll say with the utmost confidence, Jackson has the opportunity to be one of the best high school recruits out of NYC. Joining quite the list.

The 6-foot-6 prospect could arguably be one of the top prospects in the entire 2024 class. 

The Scouts are already raving on Jackson. A participant in USA Basketball will likely be there again. He’s a scoring threat and a guy that many believe could garner the top spot in the rankings for his class.

Jackson has led sturdy recruitment so far, resulting in blue blood [schools] targeting him, along with many other high-level programs.

He discussed that very recruitment with

Which schools are heavily involved early on?

“Schools that are heavily involved right now are Kansas, Oregon, UCLA, Oklahoma State, and Syracuse.”

Any new schools?

“The new schools I’ve heard from are Tennessee and Texas Tech.”

St. John’s, the hometown school, your thoughts on them?

“My thoughts on St. John’s are I enjoy watching them play I'm glad they are recruiting me, especially being a school close by home, I’m definitely excited that they’re taking a chance to recruit me.”

How about Kentucky?

“With Kentucky, I have had multiple conversations and they have been to several games throughout the season and AAU. They tell me that they really like my game and think I’ll be a great fit for their program.”

Break down the game of Ian Jackson.

“Me breaking down my game, I would say a player who takes pride in their defense, and does whatever it takes to win and can score on every level.”

What areas do you want to improve on this summer?

“I want to become a better leader on the court and become a better ball handler.”

subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.